Pradaxa Bleeding Victim Sues Drug Maker for Negligence

Pradaxa is an anti-coagulant designed to reduce the risk of stroke for patients suffering from non-valvular atrial fibrillation. Patients with this condition have an increased risk of stroke due to the formation of blood clots, which Pradaxa is designed to prevent. In some instances, however, Pradaxa can cause uncontrollable bleeding in victims who suffer a minor injury such as a fall or blow to the head.

Pradaxa belongs to a class of blood-thinners known as thrombin inhibitors. These drugs work by blocking the formation of thrombin, a protease in blood that facilitates blood clotting. Pradaxa is promoted as requiring fewer dietary restrictions compared to warfarin (Coumadin), but the promotion of Pradaxa did not include the risk of uncontrollable bleeding, or the fact that there is no antidote to Pradaxa bleeds, according to the lawsuit.

The Pradaxa lawsuit alleges that the plaintiff suffered from major Pradaxa side effects that left him with permanent physical injuries, necessitating lifelong medical monitoring and care.

The Pradaxa lawsuit alleges that the manufacturers of Pradaxa were aware – or reasonably should have been aware – of the risks associated with this drug. The complaint sites postmarket surveillance, a routine procedure for drug companies, as a means for the manufactures to have been aware of the risks of Pradaxa bleeding. The Pradaxa lawsuit also cites the fact that in other countries the manufacturers of Pradaxa were required to adopt boxed warnings before they did so in the United States, a possible indication that they were dragging their feet on warning consumers across all markets.

The Pradaxa injury lawsuit further alleges that not only did manufacturers know about the risks, but they also actively concealed these risks and continued to aggressively promote their drug. The lawsuit states that Alonzo’s physicians had received promotional materials from the makers of Pradaxa, which led to Alonzo receiving the drug.

The Pradaxa injury lawsuit is Ernesto Alonzo v. Boehringer Ingelheim Pharmaceuticals Inc., et al., Case No. 3:13-cv-51338-DRH-SCW.

It was transferred into multidistrict litigation where hundreds of similar Pradaxa injury lawsuits are consolidated. The Pradaxa MDL is In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, MDL No. 2385, in the United States District Court South District of Illinois.

Obtain a Free Pradaxa Lawsuit Evaluation

If you or someone you know suffered from serious Pradaxa side effects like uncontrollable bleeding or hemorrhaging, you have probably suffered through quite a challenging situation. Serious bleeding events, an allegedly common complication from Pradaxa, are a medical emergency that requires intensive medical care. Time under the care of emergency medical personnel usually entails considerable stress and pain, to say nothing of the mounting cost of medical care and lost wages. And unfortunately, some patients with serious bleeding events can expire from them, leaving their family and other survivors to cope with medical costs, final expenses, and lost income potential.

But you need to remember that regardless of the challenges you have found yourself facing, you still have rights, and there are steps that you can take to regain control of your situation. You can start by visiting the Pradaxa Internal Bleeding Class Action Lawsuit Investigation. Here, you can learn more about your rights and obtain a free case evaluation by a skilled Pradaxa injury lawyer.